UTMB launched the Center for Health and Clinical Outcomes Research, a university-level initiative that will serve as a central hub for developing, supporting, and accelerating health and clinical outcomes research across the institution.

"Science is a journey. You might start with a belief or an idea, but ultimately, you go where the science takes you," says Dr. Rakez Kayed, Professor of the Mitchell Center for Neurodegenerative Disorders and John Sealy Chair for Parkinson's Research at the University of Texas Medical Branch.

U.S. News & World Report named the University of Texas Medical Branch a 2025 High Performing Hospital for Maternity Care. The award is the highest a hospital can earn as part of U.S. News’ Best Hospitals for Maternity Care annual study.

The University of Texas Medical Branch Department of Pathology is the first academic healthcare center in Texas to add an artificial intelligence-based-tool to its routine workflow for the diagnosis of prostate cancer.

A new study published in the American Journal of Medicine has found that medications commonly prescribed for erectile dysfunction—tadalafil (Cialis) and sildenafil (Viagra)—are associated with significant reductions in deaths, cardiovascular disease and dementia in middle-aged men. The study was conducted by researchers at the University of Texas Medical Branch and assessed outcomes over a three-year follow-up period.

A team of researchers at UTMB has been accepted into the prestigious National Science Foundation's National I-Corps program for their groundbreaking research on traumatic brain injury detection and monitoring, with the potential to revolutionize the field.

All pregnant mothers hope for the healthy, full-term delivery of their baby. But for many mothers, that's not how things go.

The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.

Researchers at the University of Texas Medical Branch recently discovered a significant advancement in the fight against neurodegenerative diseases such as Alzheimer’s disease and dementia. The study, published today in Science Translational Medicine, introduces an innovative nasal spray treatment that has shown promising results in clearing harmful tau protein build-up and improving cognitive functions in aged mice models with neurodegenerative diseases.

Growth hormone injections significantly improved the neurologic symptoms of patients suffering from long COVID, according to a new study by researchers at the University of Texas Medical Branch.